WAVEMAN · COMPANY

ZEPP · Zepp Health Corp

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

ZEPP

Name: Zepp Health Corp (ZEPP) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Zepp Health Corp

INDUSTRIALS · ELECTRONIC COMPUTERS · CIK 0001720446

FORM 144 · 1☆ WATCH

INSIDER NET · 180D

-$45.3K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+41.8%

XBRL, annual

NET MARGIN

-15.5%

CONVERSIONS · 180D

codes C/M, not in net · $0 priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$45.3K over 180 days

-$45.3K over 90 days

more than 75% of Industrials

CONGRESS

no member of Congress has reported trading it

FUNDS

16 funds added or opened last quarter

below 86% of Industrials

REVENUE

+41.8% year over year

more than 88% of Industrials

MARGIN

-15.5% net margin

below 78% of Industrials

BUYBACKS

$1.2M repurchased, FY to 2025-12-31

below 91% of Industrials

SHORT

no short interest reported

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -90.1%

-90.1%12M

INSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows a net $45.3K sold by insiders over 180 days, 16 funds added last quarter, $47.6K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

DELL ANET TDG TSLA PANW AXON STX KTOS CRCT OFLX JOBY FTNT

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Zepp Health Corp insiders sold a net $45.3K of stock across 1 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

Deng Cheng

Chief Financial Officer

SELL

2026-06-26

9,836.0

$45.3K

1 TRANSACTION ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

MORGAN STANLEY

741,834.0 sh

$3.9M

FIL Ltd

718,178.0 sh

$3.7M

Yiheng Capital Management, L.P.

220,501.0 sh

$1.1M

Allspring Global Investments Holdings, LLC

46,748.0 sh

$243.6K

CITIGROUP INC

40,000.0 sh

$208.4K

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

Deng Cheng

FILED 2026-06-26

$47.6K

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Even Herd Long Short ETF

$98.9K POSITION · AS OF 2026-03-31

0.2%

T. Rowe Price International Discovery Fund

$4.4M POSITION · AS OF 2026-04-30

0.1%

State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF

$1.5M POSITION · AS OF 2026-03-31

0.1%

Allspring Emerging Markets Equity Fund

$816.7K POSITION · AS OF 2026-04-30

0.0%

T. Rowe Price Global Allocation Fund

$15.2K POSITION · AS OF 2026-04-30

0.0%

Emerging Markets Social Core Equity Portfolio

$23.4K POSITION · AS OF 2026-04-30

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$258.9M	$182.6M	$352.9M	$613.6M
GROSS PROFIT	$99.2M	$70.2M	$92.4M	$118.9M
OPERATING INCOME	$-29.2M	$-47.2M	$-30.4M	$-61.9M
NET INCOME	$-40.1M	$-75.7M	$-31.0M	$-43.2M
EPS (DILUTED)	-0.16	-0.29	-0.13	-0.18
OPERATING CASH FLOW	$-25.7M	$-24.4M	$42.6M	$-117.1M
CASH	$57.0M	$91.1M	$133.7M	$128.6M
LONG-TERM DEBT	$59.5M	$75.2M	$120.0M	$684.2M
BUYBACKS	$1.2M	$2.3M	$2.5M	$8.2M
DIVIDENDS PAID	—	—	—	$6.3M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE